Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 9/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29449967 | 1.00 | SIGMAR1 (0.46) | SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL6481487 | 1.00 | SIGMAR1 (0.46) | SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL3463498 | 1.00 | SIGMAR1 (0.46) | SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL15807471 | 1.00 | SIGMAR1 (0.46) | SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL75887 | 1.00 | SIGMAR1 (0.46) | SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL6123830 | 1.00 | SIGMAR1 (0.46) | SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17690821 | 1.00 | SIGMAR1 (0.46) | SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL13854486 | 1.00 | SIGMAR1 (0.46) | SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL23047 | 1.00 | SIGMAR1 (0.46) | SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL29349638 | 1.00 | SIGMAR1 (0.46) | SIGMAR1L3MBTL1ALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10700300-B2 | Organic light-emitting diode including an electron transport layer stack comprising different lithium compounds and elemental metal | NOVALED GMBH (DE) | 2020-06-30 | — | — | US | claimed |
| EP-2999019-B1 | Organic light-emitting diode including an electron transport layer stack comprising different lithium compounds and elemental metal | NOVALED GMBH (DE) | 2019-06-12 | — | — | EP | claimed |
| US-20170279064-A1 | Organic Light-Emitting Diode Including an Electron Transport Layer Stack Comprising Different Lithium Compounds and Elemental Metal | NOVALED GMBH (DE) | 2017-09-28 | — | — | US | claimed |
| EP-3195381-A1 | ORGANIC LIGHT-EMITTING DIODE INCLUDING AN ELECTRON TRANSPORT LAYER STACK COMPRISING DIFFERENT LITHIUM COMPOUNDS AND ELEMENTAL METAL | Novaled GmbH (DE) | 2017-07-26 | — | — | EP | claimed |
| EP-3002796-A1 | Organic light-emitting diode including an electron transport layer comprising a three component blend of a matrix compound and two lithium compounds | Novaled GmbH (DE) | 2016-04-06 | — | — | EP | claimed |
| EP-2999019-A1 | Organic light-emitting diode including an electron transport layer stack comprising different lithium compounds and elemental metal | Novaled GmbH (DE) | 2016-03-23 | — | — | EP | claimed |
| EP-2963696-A1 | Organic light-emitting diode (OLED) including an electron transport layer stack comprising different lithium compounds | Novaled GmbH (DE) | 2016-01-06 | — | — | EP | claimed |
| US-7175922-B2 | Aggregate organic light emitting diode devices with improved operational stability | EASTMAN KODAK COMPANY (US) | 2007-02-13 | — | — | US | claimed |
| US-20060021647-A1 | Molecular photovoltaics, method of manufacture and articles derived therefrom | SABIC INNOVATIVE PLASTICS IP B.V. | 2006-02-02 | — | — | US | claimed |
| US-6967062-B2 | White light-emitting OLED device having a blue light-emitting layer doped with an electron-transporting or a hole-transporting material or both | EASTMAN KODAK COMPANY (US) | 2005-11-22 | — | — | US | claimed |
| US-20050106415-A1 | Aggregate organic light emitting diode devices with improved operational stability | EASTMAN KODAK COMPANY | 2005-05-19 | — | — | US | claimed |
| EP-0468528-B1 | Electroluminescent device with organic electroluminescent medium | EASTMAN KODAK CO (US) | 1995-06-21 | — | — | EP | claimed |
| EP-0468528-A1 | Electroluminescent device with organic electroluminescent medium | EASTMAN KODAK COMPANY (US) | 1992-01-29 | — | — | EP | claimed |
| US-5061569-A | SUPERIOR STABILITY | EASTMAN KODAK COMPANY (US) | 1991-10-29 | — | — | US | claimed |
| US-6423429-B1 | — | — | None | — | — | US | disclosed |
| US-20250374827-A1 | Triazine Compounds Substituted with Bulky Groups | NOVALED GMBH (DE) | 2025-12-04 | — | — | US | disclosed |
| US-12433156-B2 | Triazine compounds substituted with bulky groups | NOVALED GMBH (DE) | 2025-09-30 | — | — | US | disclosed |
| US-5153088-A | High sensitivity mixture also with charge transferring substituted phenyl diamines | MITA INDUSTRIAL CO., LTD. (JP) | 1992-10-06 | — | — | US | disclosed |
| EP-0468528-A1 | Electroluminescent device with organic electroluminescent medium | EASTMAN KODAK COMPANY (US) | 1992-01-29 | — | — | EP | disclosed |
| US-5059503-A | Used for copying machine | MITA INDUSTRIAL CO., LTD. (JP) | 1991-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12433156-B2 | Triazine compounds substituted with bulky groups | CCNA1, CCNT1, CCNB1 | SIGMAR1 1644/4885L3MBTL1 1756/4885ALDH1A1 154/4885 |
| US-20250374827-A1 | Triazine Compounds Substituted with Bulky Groups | CCNA1, CCNT1, CCNL2 | SIGMAR1 1977/4885L3MBTL1 2425/4885ALDH1A1 331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.